Quantcast
Last updated on April 18, 2014 at 16:58 EDT

Latest Heart transplantation Stories

2012-06-20 02:26:59

TUCSON, Ariz., June 20, 2012 /PRNewswire/ -- On June 18, SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, was honored with two Gold Stevie® Awards at the 10th Annual American Business Awards. SynCardia won "Company of the Year - Health Products and Services" and "Most Innovative Company of the Year - up to 100 Employees." (Photo: http://photos.prnewswire.com/prnh/20120620/LA27527)...

2012-06-14 02:25:00

CHILLY-MAZARIN, France, June 14, 2012 /PRNewswire/ -- InGen BioSciences, specialised in the development and commercialisation of mono and multiparametric in vitro diagnostic tests announced a new exclusive partnership with Cylex Incorporated (Columbia, Maryland,...

2012-06-07 23:01:47

Dancer Mia Welch Bridged to Heart Transplant with SynCardia Total Artificial Heart Tucson, Ariz. (PRWEB) June 07, 2012 Last fall, 21-year-old Mia Welch took the phrase “dancing your heart out” to a whole new level. It all began in summer 2010, when she was attending Mesa Community College and dancing 14 hours a week with the school´s summer dance company. “During our summer showcase, every time I did a dance, I was exhausted, which wasn´t normal for me,”...

2012-06-07 02:25:49

TUCSON, Ariz., June 7, 2012 /PRNewswire/ -- Last fall, 21-year-old Mia Welch took the phrase "dancing your heart out" to a whole new level. It all began in summer 2010, when she was attending Mesa Community College and dancing 14 hours a week with the school's summer dance company. (Photo: http://photos.prnewswire.com/prnh/20120607/LA20552) "During our summer showcase, every time I did a dance, I was exhausted, which wasn't normal for me," said Mia. "I had to walk around with my...

2012-06-01 06:22:33

U-M Center for Circulatory Support provides leadership in research and innovation of the devices that help patients survive the wait for a heart transplant ANN ARBOR, Mich., June 1, 2012 /PRNewswire-USNewswire/ -- Math and physics teacher Darol Straub, 65, of Ann Arbor, Mich., helped high school and community college students make sense of the laws of motion, but by spring of this year his heart struggled to pump. On May 7 he was implanted with a left ventricular assist device that...

2012-05-24 02:27:49

TUCSON, Ariz., May 24, 2012 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that the SynCardia temporary Total Artificial Heart has recently replaced left ventricular assist devices (LVADs) in seven patients suffering from end-stage heart failure. (Photo: http://photos.prnewswire.com/prnh/20120524/LA13121) An LVAD is a continuous-flow, mechanical pump...

2012-05-23 14:21:34

FRAMINGHAM, Mass. and SYDNEY, May 23, 2012 /PRNewswire/ -- HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced the publication of results from ADVANCE, the Company's U.S. clinical trial evaluating the use of the HeartWare® Ventricular Assist System as a bridge to heart transplantation in patients with advanced heart...

2012-05-21 12:36:13

Statins prevent cancer and reduce death from all causes in heart transplant recipients. The findings were independent of cholesterol levels. The research was presented at the Heart Failure Congress 2012, 19-22 May, in Belgrade, Serbia. The Congress is the main annual meeting of the Heart Failure Association of the European Society of Cardiology. Cancer is the leading cause of death late after heart transplantation. Skin cancer is particularly common, but solid organ cancers including...

2012-05-21 05:27:03

(Ivanhoe Newswire) - Cancer is the leading cause of death late after heart transplantation. Now, new research shows that statins, immunomondulatory drugs, may benefit patients beyond their lipid lowering effects. Researchers in Zurich are currently investigating the impact of statin therapy on the occurrence of cancer and death from causes in heart transplantation recipients. They found the increased rate of cancer in heart transplant recipients may be related to the immune suppression of...

2012-05-17 23:01:45

A revolutionary VAD Center integrated process management solution Omaha, NE (PRWEB) May 17, 2012 OTTR Chronic Care Solutions, an Omaha-based clinical process management and informatics company, announced that they have signed an agreement with Hartford Hospital to use the OTTR Transplant Care Platform. Hartford Hospital is comprehensively using these OTTR Chronic Care Solutions´ modules and interfaces: Heart, Liver, Kidney, VAD, Financial/Insurance, Lab, ADT, SCM, CLP Lab, Allscripts,...


Latest Heart transplantation Reference Libraries

0_886104d1c1c698f3a531e056704457d5
2010-10-14 16:46:25

The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...

More Articles (1 articles) »